Patents by Inventor Jonathan David Larkin

Jonathan David Larkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF IDENTIFYING A PATIENT POPULATION
    Publication number: 20130336989
    Abstract: Provided herein is a method for identifying a patient as a candidate for treatment with an aggrecanase inhibitor. Also provided is a method of evaluating the effectiveness of an aggrecanase inhibitor.
    Type: Application
    Filed: February 24, 2012
    Publication date: December 19, 2013
    Applicant: Glaxo Group Limited
    Inventors: Fiona Germaschewski, Jonathan David Larkin, Feng Liu, Thomas Lohr
  • POLYPEPTIDES AND METHOD OF TREATMENT
    Publication number: 20120095193
    Abstract: Provided herein are isolated antigen binding protein comprising at least one first immunoglobulin variable domain capable of binding to human ADAMTS5. Also provided are antigen binding proteins of the present invention that are monoclonal antibodies, pharmaceutical compositions comprising said antigen binding proteins and methods of treatment.
    Type: Application
    Filed: July 1, 2010
    Publication date: April 19, 2012
    Inventors: Michael Neil Burden, Paul Andrew Hamblin, Jonathan David Larkin, John Richard White